Methoxsalen-d3
Modify Date: 2024-01-31 02:34:38
Methoxsalen-d3 structure
|
Common Name | Methoxsalen-d3 | ||
|---|---|---|---|---|
| CAS Number | 80386-99-8 | Molecular Weight | 219.20800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H5D3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Methoxsalen-d3Methoxsalen-d3 is the deuterium labeled Methoxsalen[1]. Methoxsalen (8-Methoxypsoralen) is a potent tricyclic furocoumarin suicide inhibitor of CYP (cytochrome P-450), is an agent used to treat psoriasis, eczema, vitiligo and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight[2]. |
| Name | 9-[(2H3)Methyloxy]-7H-furo[3,2-g]chromen-7-one |
|---|
| Description | Methoxsalen-d3 is the deuterium labeled Methoxsalen[1]. Methoxsalen (8-Methoxypsoralen) is a potent tricyclic furocoumarin suicide inhibitor of CYP (cytochrome P-450), is an agent used to treat psoriasis, eczema, vitiligo and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight[2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C12H5D3O4 |
|---|---|
| Molecular Weight | 219.20800 |
| Exact Mass | 219.06100 |
| PSA | 52.58000 |
| LogP | 2.54780 |